Skip to main content
. 2024 Sep 4;21(3):135–141. doi: 10.4274/tjod.galenos.2024.80439

Table 3. Sociodemographic characteristics, basal hormonal levels, IVF outcomes, and obstetrics results of the patients compared in between the groups.

Age

FSH

LH

AMH

E2

P4

AFC

First trigger

Rescue trigger

# Follicles on trigger day

# Follicles on 2nd egg retrieval day

# Oocytes

Oocyte

utilization rate (%)

# MII oocytes

Oocyte

maturity

index (%)

#2pn embryos

- Clevage stage embryos

# Blastocysts

Outcome

1

28

7.2

6.3

3.8

7133

0.89

42

GnRHa

rhCG

32

21

14

66.7

12

85.7

11

7

4

Positive

2

32

7.2

5.8

2.9

6647

0.72

33

DCP

hCG

24

17

11

64.7

9

81.8

7

6

3

Negative

3

31

7.9

6.1

2.3

4491

0.68

50

DCP

hCG

42

33

18

54.5

15

83.3

12

7

3

Negative

4

26

9.1

6.9

4.1

6650

0.54

38

DCP

hCG

35

28

14

50

10

71.4

9

7

4

Negative

5

37

5.5

8.1

3.3

4370

0.78

26

DCP

hCG

24

17

12

70.6

11

91.7

9

6

2

Positive

6

31

8.0

6.0

3.9

4560

0.56

32

DCP

hCG

26

16

11

68.9

8

72.7

7

6

4

Positive

IVF: In vitro fertilization, LH: Luteinizing hormone, FSH: Follicle stimulating hormone, AMH: Anti-Müllerian hormone, GnRHa:: Gonadotropin-releasing hormone agonist, 0.2 mg; rhCG: recombinant hCG, 250 g, hCG: Human chorionic gonadotropin, E2: Estradiol, P4: Progesterone, AFC: Antral follicle count, MII: Metaphase II